Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You are able to understand, agree to, and sign the official consent form before any study procedures begin
- You are willing and able to attend scheduled visits, follow the treatment plan, and complete any required tests or procedures
- You have been confirmed through a tissue sample (biopsy) to have a solid tumor
- Your cancer is at an advanced or locally advanced stage
- You are due to receive standard cancer treatment, and your specific cancer type and treatment stage matches one of the following:
- Colorectal (colon or rectal) cancer at stage IV, in the 1st, 2nd, or 3rd round of treatment
- Stomach (gastric) cancer at stage IV, in the 1st or 2nd round of treatment
- Pancreatic cancer, as a first or primary treatment
- Bile duct cancer, as a first treatment
- Liver cancer (hepatocarcinoma), in the 1st or 2nd round of treatment
- Breast cancer at stage IV, in the 1st, 2nd, 3rd, 4th, or 5th round of treatment
- Ovarian cancer at an advanced stage (FIGO III–IV), receiving chemotherapy either as initial treatment or at the time of first relapse
- Uterine (endometrial) cancer at an advanced stage (FIGO III–IV), in the 1st or 2nd round of treatment
- Advanced or locally advanced cervical cancer, in the 1st or 2nd round of treatment
- Vulva cancer that is locally advanced or has spread to other parts of the body, receiving treatment (confirm with trial site)
- Melanoma (skin cancer) in the 1st, 2nd, or 3rd round of treatment — 3rd round only if a specific gene change called BRAF mutation is present
Who may not be able to join:
- You have been diagnosed with another type of cancer within the last 3 years — exceptions may apply for certain minor skin cancers or a very early-stage cervical condition (confirm with trial site)
- You are unable or unwilling to complete the required check-ups at the four specific time points set out in the study plan
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fabio Puglisi, MD, PhD, IRCCS-Centro di Riferimento Oncologico (CRO), Aviano (PN)
Phone: 0434659253
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Real world prevalence of clinically useful mutations in solid tumors
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.